Lixte Biotechnology Holdings (LIXT) Quarterly Institutional 13F Update (Q2 2026)

Lixte Biotechnology completed its merger with Nomad Transportable Power Systems on July 1, 2026, making Nomad a wholly-owned subsidiary. In the merger, Lixte issued about 2.99 million common shares and over 50,000 shares of new Series D preferred stock (convertible into common stock at $1 per share) to Nomad shareholders. Lixte will hold a special stockholder meeting on September 4, 2026, to vote on approving the conversion of those preferred shares and other matters.